SP

Saketh Pailla Reddy

Active Director Director DIN 08379312
DIN 08379312 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Mar 2019
Shareholding value •••• Premium profile

About Saketh Pailla Reddy

Data last updated:

Saketh Pailla Reddy is a Director at Chemeca Drugs Private Limited (since 2021), Additional Director at Chemart Pharma Private Limited (since 2021) and Director at Sciegen Pharmaceuticals India Private Limited (since 2023), and holds 4 more current directorships. The companies operate in Pharma, Infrastructure and Utilities and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹144 Cr; the largest is Chemeca Drugs Private Limited at ₹128 Cr (FY 2025).

DIN 08379312
Primary Designation Director
Industry Pharma
First Appointment 04 Mar 2019
Oldest Company Age 23 yrs
Largest company Chemeca Drugs Private Limited · ₹128 Cr (FY 2025)
Combined revenue ₹144 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemeca Drugs Private Limited U24239AP2003PTC041849
Director02 Aug 20212003₹128 Cr (FY 2025)Active
Chemart Pharma Private Limited U52520TG2020PTC142822
Additional Director28 Dec 20212020₹7.80 Cr (FY 2025)Active
Director29 Apr 20232013₹6.22 Cr (FY 2024)Active
Smart Agro Food Park Private Limited U15122TG2014PTC094182
Director02 Aug 20212014₹2.44 Cr (FY 2025)Active
Director20 Jul 20232023Active
Azura Plastics Private Limited U22203TS2023PTC175007
Director14 Jul 20232023Active
Director04 Mar 20192009Active

Directorship timeline

Open interactive timeline →
Smart Agro Industries Corporation Private Limited
Smart Agro Food Park Private Limited
Bactolac Nutraceuticals Private Limited
Azura Plastics Private Limited
Premium access

Shareholding and investment profile for Saketh Pailla Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saketh Pailla Reddy

Saketh Pailla Reddy currently holds 7 directorships: Chemeca Drugs Private Limited (Director, since 02 Aug 2021, revenue ₹128 Cr (FY 2025)); Chemart Pharma Private Limited (Additional Director, since 28 Dec 2021, revenue ₹7.80 Cr (FY 2025)); Sciegen Pharmaceuticals India Private Limited (Director, since 29 Apr 2023, revenue ₹6.22 Cr (FY 2024)); Smart Agro Food Park Private Limited (Director, since 02 Aug 2021, revenue ₹2.44 Cr (FY 2025)); Bactolac Nutraceuticals Private Limited (Director, since 20 Jul 2023); and 2 more.

Saketh Pailla Reddy was first appointed on 04 Mar 2019 as Director at Smart Agro Industries Corporation Private Limited. The most recent appointment on record is 20 Jul 2023 at Bactolac Nutraceuticals Private Limited.

The 4 current companies of Saketh Pailla Reddy that report revenue have a combined latest revenue of ₹144 Cr: Chemeca Drugs Private Limited ₹128 Cr (FY 2025); Chemart Pharma Private Limited ₹7.80 Cr (FY 2025); Sciegen Pharmaceuticals India Private Limited ₹6.22 Cr (FY 2024); Smart Agro Food Park Private Limited ₹2.44 Cr (FY 2025).

The current boards of Saketh Pailla Reddy's companies include Alla Bhaskara Reddy (Chemeca Drugs Private Limited), Pailla Malla Reddy (Chemeca Drugs Private Limited), Venkata Siva Reddy Pallempalli (Chemeca Drugs Private Limited), Vishnu Vardhan Reddy Kowkuntla (Chemart Pharma Private Limited), Ganji Kishore Kumar (Smart Agro Food Park Private Limited), Kambam Ramesh Kumar (Smart Agro Food Park Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available